Posts tagged with ‘Isofol Medicial’

  • Isofol receives approval of biomarker analysis patent and intention-to-grant patent application for study dose regimen in Europe

    GOTHENBURG, Sweden, July 26, 2022 – Isofol Medical AB ( (publ) (Nasdaq Stockholm: ISOFOL), today announced the European approval for a…

  • Isofol reaches 440 patients in global Phase III AGENT study

    GOTHENBURG, Sweden, December 9, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) announces that…